Covered recipient · General Payments record
SARAH KATE MCELROY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$463.83
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $226.63 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $70.08 | 4 |
| Novo Nordisk AS | $39.68 | 2 |
| Amgen Inc. | $38.76 | 2 |
| Lilly USA, LLC | $28.98 | 1 |
| Seqirus USA Inc | $19.74 | 1 |
| Exact Sciences Corporation | $15.61 | 1 |
| GlaxoSmithKline, LLC. | $13.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.01 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117648914 | CMS |
| Amgen Inc. | $22.75 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117648916 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.50 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104579074 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.06 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104232567 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.17 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104507440 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.35 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104662885 | CMS |
| Exact Sciences Corporation | $15.61 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114485895 | CMS |
| GlaxoSmithKline, LLC. | $13.78 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115970256 | CMS |
| Lilly USA, LLC | $28.98 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135940706 | CMS |
| Novo Nordisk Inc | $23.82 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100548198 | CMS |
| Novo Nordisk Inc | $15.86 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100524919 | CMS |
| Seqirus USA Inc | $19.74 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125635825 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.